Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
We explore how clinical trials are run, and hear from a patient about what it’s like taking part in a cancer clinical trial.
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.
Category: Science blog July 21, 2016
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.
Read about how we’re approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.
Category: Science blog June 21, 2016
Discussing how the idea for a new drug can come from many different avenues.
The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men.
Category: Science blog June 3, 2016
After 15 years of painstaking work, a team of scientists have revealed the detailed structure of one of the molecules controlling a T cell’s fate.